Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics
Partnership expands spectrum of Secarna's capabilities for the development of targeted ASOs beyond antibodies and…